GlassScriptPhysician profile
David Scott Wells
NPI 1962464560
$2,676.59
in general payments reported to CMS, 2019-2025
29 companies · $238 in 2025
The $238 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $616 · 2020: $267 · 2021: $260 · 2022: $463 · 2023: $399 · 2024: $434 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,070.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $433.13 | 2019-2023 | Lo Loestrin Fe, Orilissa, Liletta |
| Astellas Pharma US INC | $302.17 | 2020-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $218.07 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $183.17 | 2020-2025 | |
| Shield Therapeutics INC | $124.35 | 2023-2025 | Accrufer |
| Pfizer INC. | $108.72 | 2019-2023 | |
| Evofem Biosciences, INC. | $108.31 | 2021-2023 | Phexxi |
| Minerva Surgical, INC | $106.58 | 2019-2021 | |
| Optumhealth Care Solutions, LLC | $98.77 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Hologic Sales and Service, LLC | $97.38 | 2019-2025 | Thinprep 2000 Processor |
| Lupin INC. | $81.86 | 2019-2020 | |
| Therapeuticsmd, INC. | $75.38 | 2019-2020 | |
| Asensus Surgical, INC. | $74.66 | 2019 | |
| Organon LLC | $64.32 | 2021-2023 | Nexplanon |
| Coloplast Corp | $63.29 | 2019-2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $60.78 | 2021-2022 | |
| Millicent US INC | $60.03 | 2019-2025 | Femring, Intrarosa |
| Sumitomo Pharma America, INC. | $59.37 | 2023-2024 | Myfembree |
| Agile Therapeutics, INC. | $50.25 | 2021-2023 | Twirla |
| Medtronic, INC. | $45.25 | 2024 | Truclear |
| Scynexis, INC. | $45.18 | 2022 | |
| Exeltis, USA INC. | $44.85 | 2021-2024 | Slynd |
| Covidien LP | $37.71 | 2020 | |
| Avion Pharmaceuticals | $32.62 | 2020-2021 | |
| Roche Diagnostics Corporation | $30.57 | 2019 | |
| Amgen INC. | $21.43 | 2019 | |
| Lsi Solutions INC | $16.91 | 2023 | Fornisee |
| Exact Sciences Corporation | $16.55 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $14.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.